Manakshe Gajendra, Chakravarthi R, Hussaini Shaista, Menon Rajeev, Srinivas Kumar A, Ravi Kiran V, Sundar Gomathi, Narasimhan C
Department of Cardiology, CARE Hospital and Research Institute, Hyderabad, India.
Indian Heart J. 2013 May-Jun;65(3):239-42. doi: 10.1016/j.ihj.2013.04.030. Epub 2013 Apr 19.
The endovascular approach of ablation of renal sympathetic nerves is found to be effective in the treatment of uncontrolled hypertension. We report here our experience with the procedure in eight patients with drug resistant hypertension.
We included patients in whom the blood pressure remained above 150/90 mmHg despite being on minimum three antihypertensive drugs. Radiofrequency ablation of the sympathetic nerves of both the renal arteries was done using conventional ablation catheters. The patients were followed at 1-month, 3 months and 6 months post procedure and blood pressure recorded.
All patients underwent successful renal sympathetic denervation. The mean blood pressure of the patients was 181/102.5 mmHg before the procedure and the average requirement of antihypertensive drugs per day was 4. A significant reduction in both systolic and diastolic blood pressure was observed post procedure which sustained over the follow up period of six months. The mean blood pressure observed at 1-month, 3 and 6 months were 137.5/80 mmHg, 136/81 mmHg and 137.5/81 mmHg, respectively. The average requirement of the number of antihypertensives also was reduced to 2.5 at the end of 6 months. There were no procedural complications.
Catheter based renal denervation causes substantial and sustained blood pressure reduction without serious adverse events in patients with resistant hypertension.
肾交感神经消融的血管内治疗方法被发现对治疗难治性高血压有效。我们在此报告我们对8例耐药性高血压患者进行该手术的经验。
我们纳入了尽管使用了至少三种抗高血压药物但血压仍保持在150/90 mmHg以上的患者。使用传统消融导管对双侧肾动脉的交感神经进行射频消融。在术后1个月、3个月和6个月对患者进行随访并记录血压。
所有患者均成功进行了肾交感神经去神经支配。患者术前平均血压为181/102.5 mmHg,每天平均需要4种抗高血压药物。术后观察到收缩压和舒张压均显著降低,且在6个月的随访期内持续存在。在1个月、3个月和6个月时观察到的平均血压分别为137.5/80 mmHg、136/81 mmHg和137.5/81 mmHg。6个月末抗高血压药物的平均使用数量也减少到了2.5种。没有手术并发症。
对于耐药性高血压患者,基于导管的肾去神经支配可显著且持续地降低血压,且无严重不良事件。